Global Antibody Discovery Services Market Set to Soar Past $1.6 Billion by 2023: Aiding Pharmaceutical Efficiency Through Outsourcing
18 oct. 2023 06h13 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
06 juin 2023 03h00 HE
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
15 mai 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Reports First Quarter 2023 Financial Results
11 mai 2023 16h05 HE
|
Telesis Bio
-- Total revenue of $6.3M in 1QFY23 -- BioXp® franchise revenue increased by 28% SAN DIEGO, May 11, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and...
Antibody Discovery Market to Reach $17.2 Billion, Globally, by 2032 at 9.6% CAGR: Allied Market Research
03 mai 2023 06h30 HE
|
Allied Market Research
Portland, OR, May 03, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Antibody Discovery Market by Methods (Phage Display, Hybridoma, Others), by Antibody Type...
Telesis Bio to Report First Quarter Financial Results on Thursday, May 11, 2023
27 avr. 2023 16h05 HE
|
Telesis Bio
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its first quarter...
Telesis Bio to Present at Festival of Biologics Conference
16 mars 2023 06h00 HE
|
Telesis Bio
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced Daniel Gibson, Ph.D., CTO and...
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
22 juin 2022 08h35 HE
|
Berkeley Lights, Inc
EMERYVILLE, Calif., June 22, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 27th Annual European Society for...
Berkeley Lights to Participate in the 18th Annual PEGS Boston Conference & Expo
29 avr. 2022 12h30 HE
|
Berkeley Lights, Inc
EMERYVILLE, Calif., April 29, 2022 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, today announced its participation at the 18th Annual PEGS Boston...
Vaccinex, Inc. Announces Upcoming Presentation at the PEGS Boston Conference & Expo Highlighting Its ActivMAb® Technology for Complex Membrane Antigen Expression to Enable Drug Discovery
25 avr. 2022 08h00 HE
|
Vaccinex, Inc.
ROCHESTER, N.Y., April 25, 2022 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating cancer and...